Article
Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling.
BMC infectious diseases - 19 Feb 2014
Deleré Yvonne, Remschmidt Cornelius, Leuschner Josefine, Schuster Melanie, Fesenfeld Michaela, Schneider Achim, Wichmann Ole, Kaufmann Andreas M
Abstract excerpt
BACKGROUND: Estimates of Human Papillomavirus (HPV) prevalence in a population prior to and after HPV vaccine introduction are essential to evaluate the short-term impact of vaccination. METHODS: Between 2010 and 2012 we conducted a population-based cross-sectional study in Germany to determine HPV prevalence, genotype distribution and risk factors for HPV-infection in women aged 20-25 years. Women were recruited...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.